DANVERS, Mass., May 10, 2010 (BUSINESS WIRE) -- Abiomed, Inc. (NASDAQ: ABMD) announced today that on Wednesday, May 19, 2010, the Company will release financial results for the fourth quarter and full year of fiscal 2010. The Company will host a conference call to discuss the results on Wednesday, May 19, 2010, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer, will host the conference call.
To listen to the call live, please tune into the webcast via http://investor.abiomed.com or dial 866.770.7129; the international number is 617.213.8067. The access participant code is 64191812. A replay of this conference call will be available beginning at 11 a.m. ET on May 19, 2010 through 11:59 p.m. ET on June 2, 2010. The replay phone number is 888.286.8010; the international number is 617.801.6888. The replay access code is 64963529.
ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.
FORWARD-LOOKING STATEMENTS This Release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the Annual Report filed on Form 10-K and the most recently filed Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.
SOURCE: Abiomed, Inc.
CONTACT: Abiomed, Inc. Aimee Maillett, 978-646-1553 Public Relations Specialist email@example.com Copyright Business Wire 2010 -0- KEYWORD: United States
Massachusetts INDUSTRY KEYWORD: Health
Medical Devices SUBJECT CODE: Advisory